Pacific Biosciences Of California | PACB - Umlaufvermögen

Aktienkurs
1.65
Täglich Wechseln
0.07 4.43%
Monatlich
14.58%
Jährlich
46.02%
Q2 Prognose
1.57




Umlaufvermögen Veränderung Datum
Agilent USD 4.62B 21M 2025-12
Bruker USD 2.1B 108.9M 2026-03
Danaher USD 13.94B 1.18B 2026-03
General Electric Aerospace USD 40.36B 235M 2026-03
Illumina USD 2.74B 551M 2026-03
Myriad Genetics USD 312.8M 19.8M 2026-03
Pacific Biosciences Of California USD 375.05M 19.18M 2025-12
Quidel USD 1.38B 70.3M 2026-03
Revvity USD 2.13B 111.43M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Standard Biotools USD 454.26M 18.18M 2025-12
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Waters USD 3.72B 1.73B 2026-03